黄体数量对母体妊娠及出生结局的影响:鹿特丹围孕期队列研究
本研究基于鹿特丹围孕期前瞻性队列,纳入1861例单胎妊娠,探讨辅助生殖技术(ART)所致黄体(CL)数量改变与母体妊娠及出生结局的关联。结果显示,与自然妊娠(1个CL)相比,无CL(0 CL)与妊娠期糖尿病风险升高相关(aOR 2.59,95%CI 1.31-5.15),子痫前期风险虽升高但未达统计学显著(aOR 2.02,95%CI 0.91-4.51);与>1 CL相比,0 CL的子痫前期风险显著降低(aOR 0.36,95%CI 0.18-0.72)。作者认为异常黄体数量可能影响母体妊娠和/或出生结局,需进一步研究其原因和病理生理机制。
要点
- 与自然妊娠(1 CL)相比,0 CL与妊娠期糖尿病风险升高相关(aOR 2.59,95%CI 1.31-5.15)。
- 与>1 CL相比,0 CL的子痫前期风险显著降低(aOR 0.36,95%CI 0.18-0.72)。
- 男性新生儿中,>1 CL与出生体重百分位降低相关(aβ -6.18,95%CI -11.16至-1.20);女性新生儿中0 CL与出生体重百分位升高相关(aβ 12.93,95%CI 2.52-23.34)。
核心结论
- 妊娠期高血压疾病、妊娠期糖尿病和相对出生体重的风险在黄体组间存在差异,支持异常黄体数量影响母体妊娠和/或出生结局的假说。
- 需开展更多研究探讨其原因和潜在病理生理机制。
研究设计与样本
- 研究嵌套于鹿特丹围孕期队列,该队列为荷兰鹿特丹伊拉斯姆斯大学医学中心正在进行的三级中心前瞻性队列。
- 纳入1861例有黄体数据的单胎妊娠。
- 暴露按受孕方式分为0个黄体(人工周期冻胚移植,n=72)、>1个黄体(卵巢刺激新鲜胚胎移植,n=462)和1个黄体(自然周期冻胚移植及自然妊娠,n=1327)。
- 主要结局为妊娠期高血压疾病、妊娠期糖尿病、出生时孕龄和出生体重,源自医疗记录。
- 分析校正了母亲年龄、母亲体重指数、未产和产科病史。
主要发现
- 与自然妊娠(1 CL)相比,0 CL与妊娠期糖尿病风险升高相关(aOR 2.59,95%CI 1.31-5.15)。
- 与自然妊娠(1 CL)相比,0 CL与子痫前期风险升高相关但未达统计学显著(aOR 2.02,95%CI 0.91-4.51)。
- 与>1 CL相比,0 CL的子痫前期风险显著降低(aOR 0.36,95%CI 0.18-0.72)。
- 事后分析显示,男性新生儿中>1 CL与出生体重百分位降低相关(aβ -6.18,95%CI -11.16至-1.20)。
- 女性新生儿中>1 CL无关联,而0 CL与出生体重百分位升高相关(aβ 12.93,95%CI 2.52-23.34)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate associations between assisted reproductive technology (ART)-induced alterations in corpus luteum (CL) number during implantation, and maternal pregnancy and birth outcomes. Pregnancies conceived through ART are associated with increased risks of adverse obstetric and perinatal outcomes, with discrepancies in outcomes between different ART treatment protocols. We hypothesize that this is because the periconceptional hormonal environment regulated by the CL. Assisted reproductive technology protocols affect CL quantity at conception resulting in CL absence or a supraphysiological number of CL. DESIGN: This study is embedded in the Rotterdam Periconceptional Cohort, an ongoing tertiary center prospective cohort at the Erasmus University Medical Center in Rotterdam, the Netherlands. SUBJECTS: Women with a singleton pregnancy with data on CL. EXPOSURE: The number of CL, based on mode of conception: 0 CL (artificial-cycle frozen embryo transfer, n = 72); >1 CL (ovarian stimulated fresh embryo transfer, n = 462), and 1 CL (natural-cycle frozen embryo transfer and natural conceptions, n = 1327). MAIN OUTCOME MEASURES: Hypertensive disorders of pregnancy, gestational diabetes, gestational age at birth and birthweight, derived from medical records. RESULTS: We included 1,861 pregnancies. The results were adjusted for maternal age, maternal body mass index, nulliparity, and obstetric history. In comparison with natural conceptions (1 CL), a pregnancy with CL absence (0 CL) was associated with a higher risk of gestational diabetes (adjusted odds ratio [aOR]: 2.59 [95% confidence interval (CI): 1.31-5.15]), and a higher risk of preeclampsia, albeit non-significantly (aOR: 2.02 [95% CI: 0.91-4.51]). In comparison with pregnancies with >1 CL, the risk of preeclampsia was significantly lower (aOR: 0.36 [95% CI: 0.18-0.72]). Post hoc analyses revealed that in male neonates, >1 CL was associated with a lower birthweight percentile (aβ; -6.18 [95% CI: -11.16 to -1.20]). In contrast, female neonates showed no association with >1 CL, whereas CL absence was associated with a higher birthweight percentile (aβ: 12.93 [95% CI: 2.52-23.34]). CONCLUSIONS: Risks of hypertensive disorders of pregnancy, gestational diabetes, and relative birthweight differ between CL groups. These findings support the hypothesis that an aberrant number of CL impacts maternal pregnancy and or birth outcomes. Additional studies need to be conducted to investigate causes and underlying pathophysiology. CLINICAL TRIAL REGISTRATION NUMBER: NL4115 (https://onderzoekmetmensen.nl/en/trial/25560; date of registration: October 15, 2004; date of enrollment first subject: November 4, 2010).
引用
- Koerts JJ, Voskamp LW, Rousian M, et al. Impact of corpus luteum number on maternal pregnancy and birth outcomes: the Rotterdam Periconception Cohort. Fertil Steril. 2024. PMID: 39644989. doi:10.1016/j.fertnstert.2024.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。